The present invention relates to a 制药 composition for treating 角膜损伤 containing 8-oxo-2'-deoxyguanosine or a 制药ly acceptable salt thereof as an active ingredient. Specifically, when administered by 滴眼液 in an ethanol-induced 角膜损伤 小鼠模型, it was ultimately confirmed that 角膜上皮 recovery (regeneration) was accelerated and 角膜 clarity was improved compared to the control group.
Thus, the 8-oxo-2'-deoxyguanosine of the present invention can be usefully used in the treatment of 角膜损伤.
← 返回列表Company ← 返回列表
含有8-oxo-2’-deoxyguanosine的角膜损伤治疗药物组合物
2020-02-07